Study of Mapatumumab in Combination With Bortezomib (Velcade) and Bortezomib Alone in Subjects With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT00315757 · COMPLETED
Trial details
- NCT number
- NCT00315757
- Sponsor
- Human Genome Sciences Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2010-10-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.